| Business Summary | | CNS,
Inc.
is
in
the
business
of
developing
and
marketing
consumer
health
care
products,
including
the
Breathe
Right
nasal
strip.
The
Breathe
Right
nasal
strip
improves
breathing
by
reducing
nasal
airflow
resistance.
It
can
be
effective
in
providing
temporary
relief
for
nasal
congestion,
reducing
snoring
and
reducing
breathing
difficulties
due
to
a
deviated
nasal
septum.
In
2000,
the
Company
expanded
its
Breathe
Right
product
line
to
include
nasal
strips
for
colds
with
Vicks
mentholated
vapors
that
are
sized
for
the
entire
family,
and
nasal
strips
for
children
that
are
available
in
multiple
colors. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | CNS,
Inc.
develops
and
markets
consumer
health
care
products,
including
the
Breathe
Right
nasal
strip.
The
Breathe
Right
nasal
strip
improves
breathing
by
reducing
nasal
airflow
resistance.
For
the
six
months
ended
6/30/01,
revenues
rose
52%
to
$42.6
million.
Net
loss
rose
3%
to
$6.6
million.
Revenues
reflect
increased
international
sales
of
Breathe
Right
nasal
strips
in
Japan.
Net
loss
reflects
increased
advertising
expenses
and
$1.1
million
restructuring
charge. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Daniel Cohen, M.D., 48 Chairman | $384K | Marti Morfitt, 43 Pres,
CEO, Director | 421K | David Byrd, 47 CFO,
VP-Fin., Treasurer | -- | Larry Muma, 50 VP-Operations | -- | John Keppeler, 39 VP
of Worldwide Sales | 238K | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|